Showing 601-610 of 3024 results for "".
Practice Management Deadlines Loom for Clinical Neurologists
https://practicalneurology.com/columns/practice-management/practice-management-deadlines-loom-for-clinical-neurologists/30811/Learn what you need to do to comply with new initiatives and protect your practice from fines and penalties.FDA Filing for Cannabidiol, Data on Diet and Exercise and Brain Aging and Memory, Boston Scientific Indication for DBS
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/fda-filing-for-cannabidiol-data-on-diet-and-excercise-and-brain-aging-and-memory-boston-scientific-indication-for-dbs/30285/Evidence Lost? Epilepsy Surgery Not as Common as It Should Be
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/evidence-lost-epilepsy-surgery-not-as-common-as-it-should-be/30768/Doctors stress the importance of evidence-based medicine. So why aren't more patients having epilepsy surgery?Neurologists' Experiences with EHRs: The Texas Perspective
https://practicalneurology.com/columns/practice-management/neurologists-experiences-with-ehrs-the-texas-perspective/30779/The Texas Neurological Society surveyed its membership about their experiences with EHRs. Results show generally moderate to low satisfaction.Medical Marijuana and Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-movement-disorders/31951/Medical marijuana can be a useful tool for addressing nonmotor symptoms of movement disorders.Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-what-do-animal-models-ofalzheimers-disease-tell-us/31560/Understanding pathologic mechanisms provides test beds for finding treatments.Evaluating Heterogeneous Treatment Effects in Pursuit of Personalized Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/evaluating-heterogeneous-treatment-effects-in-pursuit-of-personalized-multiple-sclerosis-care/33141/Heterogeneous treatment effect methodologies can be used to enhance individualized care for people with multiple sclerosis.Headache Horizons: Reversible Cerebral Vasoconstriction Syndrome: Presentation, Diagnosis, and Treatment of a Complex Neurovascular Disorder
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-reversible-cerebral-vasoconstriction-syndrome-presentation-diagnosis-and-treatment-of-a-complex-neurovascular-disorder/32145/Early diagnosis of and intervention for reversible cerebral vasoconstriction syndrome produce a more favorable outcome, limiting potentially disabling or fatal sequelae.Neurologic Assessment & Neuromonitoring in the COVID-19 Pandemic
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-assessment-neuromonitoring-in-the-covid-19-pandemic/31742/Noninvasive monitoring can help triage, monitoring at-risk persons, and assess the need for invasive monitoring modalities.Understanding Disparities Associated with Alzheimer Disease and Related Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/understanding-disparities-associated-with-alzheimer-disease-and-related-dementias/32142/Clinicians need to take into consideration a variety of factors resulting in disparities in health outcomes in people with dementia, including socioeconomic status, race, ethnicity, environment, life experiences, and culture.